These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 7856508)

  • 21. Importance of following instructions when compounding.
    Swenson CF
    Am J Hosp Pharm; 1993 Feb; 50(2):261. PubMed ID: 8480777
    [No Abstract]   [Full Text] [Related]  

  • 22. Bulk compounding technology.
    Schumacher GE
    Am J Hosp Pharm; 1968 Nov; 25(11):661-2. PubMed ID: 5696167
    [No Abstract]   [Full Text] [Related]  

  • 23. Application of standards for compounding.
    Newton DW
    J Am Vet Med Assoc; 1994 Jul; 205(2):232-4. PubMed ID: 7928584
    [No Abstract]   [Full Text] [Related]  

  • 24. Preparation of silymarin proliposome: a new way to increase oral bioavailability of silymarin in beagle dogs.
    Yan-yu X; Yun-mei S; Zhi-peng C; Qi-neng P
    Int J Pharm; 2006 Aug; 319(1-2):162-8. PubMed ID: 16687221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of newly revised sterile medication compounding guidelines USP {797} on allergy vial preparation.
    Lin SY; Houser SM; Gross G; Aaronson D
    Otolaryngol Head Neck Surg; 2008 Jul; 139(1):5-6. PubMed ID: 18585553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protecting consumers from counterfeit drugs.
    FDA Consum; 2004; 38(3):12-3. PubMed ID: 15218838
    [No Abstract]   [Full Text] [Related]  

  • 27. ASHP technical assistance bulletin on compounding nonsterile products in pharmacies. American Society of Hospital Pharmacists.
    Am J Hosp Pharm; 1994 Jun; 51(11):1441-8. PubMed ID: 7942879
    [No Abstract]   [Full Text] [Related]  

  • 28. Importance of maintaining and promoting prescription compounding skills.
    Swerling R
    Am J Hosp Pharm; 1979 Nov; 36(11):1477-8. PubMed ID: 517528
    [No Abstract]   [Full Text] [Related]  

  • 29. Application of the Food and Drug Administration's current good manufacturing practices regulations to pharmacy practice: a legal view.
    Fink JL
    Contemp Pharm Pract; 1979; 2(4):202-5. PubMed ID: 10244540
    [No Abstract]   [Full Text] [Related]  

  • 30. Current good manufacturing practices for PET drug products in the United States.
    Swanson D; Graham M; Heinonen TM; Libby P; Mills GQ
    J Nucl Med; 2009 Aug; 50(8):26N-8N. PubMed ID: 19652213
    [No Abstract]   [Full Text] [Related]  

  • 31. USP general chapter <797> pharmaceutical compounding-sterile preparations.
    Hung JC
    J Nucl Med; 2004 Jun; 45(6):20N, 28N. PubMed ID: 15181114
    [No Abstract]   [Full Text] [Related]  

  • 32. [DATA ON THE DETERMINATION OF PARTICLE SIZE IN SUSPENSION OINTMENTS].
    LIUKSHENKOV AG; BLAGOVIDOVA IuA; LOGINTSEVA GA
    Aptechn Delo; 1963; 12():30-6. PubMed ID: 14072493
    [No Abstract]   [Full Text] [Related]  

  • 33. Stability of extemporaneous enalapril maleate suspensions for pediatric use prepared from commercially available tablets.
    Sosnowska K; Winnicka K; Czajkowska-Kośnik A
    Acta Pol Pharm; 2009; 66(3):321-6. PubMed ID: 19645333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Precautions followed by personnel involved with the preparation of parenteral antineoplastic medications.
    Tortorici MP
    Hosp Pharm; 1980 Jun; 15(6):293, 295-6, 298-9 passim. PubMed ID: 10247268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Problems associated with veterinary compounding in swine practice.
    McKean JD
    J Am Vet Med Assoc; 1994 Jul; 205(2):279-83. PubMed ID: 7928598
    [No Abstract]   [Full Text] [Related]  

  • 36. The choice of lipids and surfactants for injectable extravenous microspheres.
    Pietkiewicz J; Sznitowska M
    Pharmazie; 2004 Apr; 59(4):325-6. PubMed ID: 15125585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. "Double, double, toil and trouble': for modern practitioners of compounding, standards and training are critical [interview by Lisa Santandrea].
    Allen LV
    Am J Nurs; 2003 May; 103(5):83. PubMed ID: 12762333
    [No Abstract]   [Full Text] [Related]  

  • 38. Report on the PQRI impurity characterization and quantification best practices survey.
    Faustino P; Chan CC; Carrano J; Gosnell M; Gu ZQ; Maule A; Sigvardson K; Zhang YF
    Pharm Res; 2006 Feb; 23(2):440-6. PubMed ID: 16477396
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of compounding and storage conditions on stability of pergolide mesylate.
    Davis JL; Kirk LM; Davidson GS; Papich MG
    J Am Vet Med Assoc; 2009 Feb; 234(3):385-9. PubMed ID: 19210262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stability of sulfadiazine oral liquids prepared from tablets and powder.
    Pathmanathan U; Halgrain D; Chiadmi F; Schlatter J; Vermerie N
    J Pharm Pharm Sci; 2004 Apr; 7(1):84-7. PubMed ID: 15144740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.